Clinical Trial Update: Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa [Phase 2]

View source ↗

Summary

A Phase 2 trial in West and Central Africa evaluated interferon-free sofosbuvir plus ribavirin for genotype 2 and sofosbuvir/ledipasvir for genotypes 1 and 4 He…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Ledipasvir (ledipasvir)
• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)
• Sofosbuvir/Ledipasvir (sofosbuvir/ledipasvir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Hepatitis C, HIV Infection | Phase 2 | Status: COMPLETED